N-[3-(3-carbazol-9-ylnaphthalen-1-yl)phenyl]-N-(4-phenylphenyl)dibenzofuran-4-amine
C52H34N2O — CID 168809217
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[3-(3-carbazol-9-ylnaphthalen-1-yl)phenyl]-N-(4-phenylphenyl)dibenzofuran-4-amine
N-[3-(3-carbazol-9-ylnaphthalen-1-yl)phenyl]-N-(4-phenylphenyl)dibenzofuran-4-amine (PubChem CID 168809217) has the molecular formula C52H34N2O and a molecular weight of 702.86 g/mol. Its IUPAC name is N-[3-(3-carbazol-9-ylnaphthalen-1-yl)phenyl]-N-(4-phenylphenyl)dibenzofuran-4-amine.
Molecular Properties
| Compound Name | N-[3-(3-carbazol-9-ylnaphthalen-1-yl)phenyl]-N-(4-phenylphenyl)dibenzofuran-4-amine |
|---|---|
| PubChem CID | 168809217 |
| Molecular Formula | C52H34N2O |
| Molecular Weight | 702.86 g/mol |
| Exact Mass | 702.27 |
| IUPAC Name | N-[3-(3-carbazol-9-ylnaphthalen-1-yl)phenyl]-N-(4-phenylphenyl)dibenzofuran-4-amine |
| SMILES | c1ccc(-c2ccc(N(c3cccc(-c4cc(-n5c6ccccc6c6ccccc65)cc5ccccc45)c3)c3cccc4c3oc3ccccc34)cc2)cc1 |
| InChI | InChI=1S/C52H34N2O/c1-2-14-35(15-3-1)36-28-30-39(31-29-36)53(50-26-13-23-46-45-22-8-11-27-51(45)55-52(46)50)40-18-12-17-38(32-40)47-34-41(33-37-16-4-5-19-42(37)47)54-48-24-9-6-20-43(48)44-21-7-10-25-49(44)54/h1-34H |
| InChIKey | URJRRPJGWSDWFH-UHFFFAOYSA-N |
| XLogP | 14.64 |
| TPSA | 21.31 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 55 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 702.86 |
| LogP ≤ 5 | 14.64 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 168809217 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.